Caution need to be exercised when people previously presented Simulect are re-subjected to a subsequent course of therapy with this medicinal product or service. There exists accumulating evidence that a subgroup of sufferers is at an increased danger of acquiring hypersensitivity reactions. These are typically individuals in whom, next the initial